CN104840784A - Vitiligo eliminating ointment - Google Patents
Vitiligo eliminating ointment Download PDFInfo
- Publication number
- CN104840784A CN104840784A CN201510209162.0A CN201510209162A CN104840784A CN 104840784 A CN104840784 A CN 104840784A CN 201510209162 A CN201510209162 A CN 201510209162A CN 104840784 A CN104840784 A CN 104840784A
- Authority
- CN
- China
- Prior art keywords
- radix
- root
- vitiligo
- rhizoma
- ramulus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Vitiligo eliminating ointment comprises, by weight, 20 to 30g of malaytea scurfpea fruit, 20 to 30g of drynaria rhizome, 8 to 12g of sorghum root, 20 to 30g of anthelmintic ironweed stem, 10 to 20g of white tea, 8 to 12g of Japanese ampelopsis root, 4 to 6g of java brucea fruit, 8 to 12g of paniculate swallowwort root, 8 to 12g of Chinese starjasmine stem, 10 to 20g of resinadraconis, 8 to 12g of black catechu, 8 to 12g of shrubalthea bark, 4 to 6g of sea horse, 4 to 6g of divaricate saposhnikovia root, 4 to 6g of reed rhizome, 8 to 12g of light yellow sophora root, 8 to 12g of glabrous greenbrier rhizome, 8 to 12g of peony root, 4 to 6g of siegesbeckia herb, and 4 to 6g of mulberry twig. The ointment has the advantages that compatibility is reasonable, and therapeutic effect on segmental vitiligo is good; by being externally applied, pathogenic wind-toxic is relieved, nutritional blood is harmonized, skin permeability is enhanced, melanocytes are stimulated to revive and regenerate, superficial body resistance is strengthened to clear away wind, and invigorating kidney and strengthening foundation can be achieved.
Description
Technical field
The present invention relates to medical art, be specifically related to one and remove vitiligo cream.
Background technology
Vitiligo divides completeness white macula and imperfection white macula two types.It is a kind of common multiple pigmented dermatosis.This disease forms white macula for feature with local or general property depigmentation, is a kind of acquired limitation or general property depigmentation of skin, and be the common skin diseases of an impact beauty treatment, easily diagnose, treatment is difficult.Traditional Chinese medical science medical science is referred to as " vitiligo " or " vitiligo ".Vitiligo is the limitation white patch that posteriority occurs because of skin pigment depigmentation, makes local skin be white macula sample.Medically usually this pathological changes depigmentation.This disease all has generation all over the world, and India's sickness rate is the highest, and China about has tens of millions of people to fall ill, and can involve all races, men and women falls ill without marked difference.
The traditional Chinese medical science is thought, lung governing qi, main white.White macula is due to insufficiency of vital energy and blood, makes skin must not nutrition and bleaching.Leukodermic morbidity is the synergistic result of body internal and external factor, it is interior because liver spleen is suffered from a deficiency of the kidney, how by deficiency of liver-blood, insufficiency of kidney-YANG, deficiency of kidney-QI, cause and make body yin and yang imbalance, qi-blood disharmony, damp and hot ailment said due to cold or exposure is taken advantage of a weak point on this basis, and visitor enters skin, impatency meridians blood vessels, skin must not be warm, and skin and hair loses to support and causes incontinentia pigmentosa achromians and form white macula.Traditional Chinese medical science curing vitiligo many employings QI and blood regulating, Shugan Bushen, the method for dispelling wind and removing obstruction in the collateral.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of combination simple, is eutherapeuticly used for the treatment of leukodermic Chinese medicinal ointment.
Technical problem to be solved by this invention realizes by the following technical solutions:
One removes vitiligo cream, is made up of the component of following weight: Fructus Psoraleae 20-30g, Rhizoma Drynariae 20-30g, Radix Sorghum vulgare Pers. 8-12g, Caulis Vernoniae andersonii 20-30g, Ramulus et Folium Mussaendae Pubescentis 10-20g, Radix Ampelopsis 8-12g, Fructus Bruceae 4-6g, Radix Cynanchi Paniculati 8-12g, Caulis Trachelospermi 8-12g, Sanguis Draxonis 10-20g, catechu 8-12g, Cortex Hibisci 8-12g, Hippocampus 4-6g, Radix Saposhnikoviae 4-6g, Rhizoma Phragmitis 4-6g, Radix Sophorae Flavescentis 8-12g, Rhizoma Smilacis Glabrae 8-12g, Radix Paeoniae Rubra 8-12g, Herba Siegesbeckiae 4-6g, Ramulus Mori 4-6g.
The better weight proportion of above-mentioned each taste medicine is: Fructus Psoraleae 25g, Rhizoma Drynariae 25g, Radix Sorghum vulgare Pers. 10g, Caulis Vernoniae andersonii 25g, Ramulus et Folium Mussaendae Pubescentis 15g, Radix Ampelopsis 10g, Fructus Bruceae 5g, Radix Cynanchi Paniculati 10g, Caulis Trachelospermi 10g, Sanguis Draxonis 15g, catechu 10g, Cortex Hibisci 10g, Hippocampus 5g, Radix Saposhnikoviae 5g, Rhizoma Phragmitis 5g, Radix Sophorae Flavescentis 10g, Rhizoma Smilacis Glabrae 10g, Radix Paeoniae Rubra 10g, Herba Siegesbeckiae 5g, Ramulus Mori 5g.
Preparation method: the mode effective component extracting each taste medicine in above-mentioned Recipe of external-use medicine being adopted respectively water extraction or ethanol extraction, by the effective ingredient mixing of extracting, loads in bottle stand-by.
Usage: during use, gets appropriate medicated powder, instant with 97% ethanol, and darken blue rear wiping site of disease.General one month is a course for the treatment of, and 3-6 the course for the treatment of takes effect.
Medicine is avoided: 1) should wash away medicinal liquid, with anti-foaming after local application's number minute.As there is erythema, blister, should suspend medication, can continue to use after to be restored.2) ban on opium-smoking and the opium trade wine.
Clinical observation: normal use 3-7 days white maculas redden, and white macula edge forms in white and black border, progressively tends towards stability, and area no longer expands, and after 30 days, white macula is no longer newly sent out, and white macula position has thickly dotted black vegetarian refreshments to produce.The white macula of about 2-3 month general coin-size can rehabilitation, and about 4-6 month egg size white macula can rehabilitation, and the white macula that about 10-12 month palm is large can rehabilitation.
In medical material provided by the present invention:
Fructus Psoraleae: the furocoumarin class materials such as the psoralen contained, isopsoralen, skin can be strengthened ultraviolet sensitivity, suppression epidermis are dredged to base activity, improve tyrosinase activity, promoted the effects such as melanocyte synthesis melanocyte, can make that skin pigment increases, color burn, be principal agent;
Rhizoma Drynariae: have invigorating blood circulation, stop blooding, the merit of reuniting the fractured tendons and bones is accessory drugs;
Vitiligo skin lesion is put on the skin outside place, can make that local melanocyte quantity increases, function strengthens, melanin regeneration and play the effect of white macula secondary color.
All medicines in external side: deintoxication, and nutrient blood, increase cutaneous permeability, stimulate melanocyte nucleus formation, and treatment vitiligo imperfection white macula has good curative effect.
The present invention, by Caulis Vernoniae andersonii and the same use of Fructus Psoraleae, Rhizoma Drynariae, Sanguis Draxonis and Ramulus et Folium Mussaendae Pubescentis, changes the mode of tradition as oral medicine, is prepared into liniment, improves drug effect, and powder is easy to preserve, and uses and also facilitates.
Clinical experiment
1, case source
Choose 550 routine patients with vitiligo at each large Dermatology of this city, topical type in patient, distribute type, acra type, general hair style, segmental pattern all have.Wherein male 240 example, women 310 example, the course of disease half a year by 8 years between, average course of disease is 3.23, patient age 8-50 year between.
2, test method
Patient uses medicine wiping affected part of the present invention, every day 4 times, each 2 times sooner or later, and every minor tick 30 minutes, uses 3 months continuously.
3, criterion of therapeutical effect
Effective: white macula disappears completely or white spot area reduces and is greater than 70%;
Effective: white spot area reduces, white spot area reduces and is greater than 50%;
Invalid: the unchanged or white spot area of white macula reduces and is less than 10%.
4, therapeutic outcome
| Number of cases | Effective | Effectively | Invalid | Effective percentage (%) |
| 550 | 252 | 290 | 8 | 98 |
The invention has the beneficial effects as follows: compatibility of the present invention is reasonable, this medicine adopts the mode of external treatment, external side's deintoxication, and nutrient blood, increase cutaneous permeability, stimulate melanocyte to bring back to life, become again, can consolidating superficial resistance dispel the wind, reinforcing kidney and strengthening resistance and nutrient blood, treatment vitiligo imperfection white macula has good curative effect.
Detailed description of the invention
The technological means realized to make the present invention, creation characteristic, reaching object and effect is easy to understand, below in conjunction with specific embodiment, setting forth the present invention further.
Embodiment 1
One removes vitiligo cream, is made up of the component of following weight: Fructus Psoraleae 25g, Rhizoma Drynariae 25g, Radix Sorghum vulgare Pers. 10g, Caulis Vernoniae andersonii 25g, Ramulus et Folium Mussaendae Pubescentis 15g, Radix Ampelopsis 10g, Fructus Bruceae 5g, Radix Cynanchi Paniculati 10g, Caulis Trachelospermi 10g, Sanguis Draxonis 15g, catechu 10g, Cortex Hibisci 10g, Hippocampus 5g, Radix Saposhnikoviae 5g, Rhizoma Phragmitis 5g, Radix Sophorae Flavescentis 10g, Rhizoma Smilacis Glabrae 10g, Radix Paeoniae Rubra 10g, Herba Siegesbeckiae 5g, Ramulus Mori 5g.
Preparation method: the mode effective component extracting each taste medicine in above-mentioned Recipe of external-use medicine being adopted respectively water extraction or ethanol extraction, by the effective ingredient mixing of extracting, loads in bottle stand-by.
Usage: during use, gets appropriate medicated powder, instant with 97% ethanol, and darken blue rear wiping site of disease.General one month is a course for the treatment of, and 3-6 the course for the treatment of takes effect.
Medicine is avoided: 1) should wash away medicinal liquid, with anti-foaming after local application's number minute.As there is erythema, blister, should suspend medication, can continue to use after to be restored.2) ban on opium-smoking and the opium trade wine.
Embodiment 2
One removes vitiligo cream, is made up of the component of following weight: Fructus Psoraleae 30g, Rhizoma Drynariae 20g, Radix Sorghum vulgare Pers. 12g, Caulis Vernoniae andersonii 20g, Ramulus et Folium Mussaendae Pubescentis 20g, Radix Ampelopsis 8g, Fructus Bruceae 6g, Radix Cynanchi Paniculati 8g, Caulis Trachelospermi 12g, Sanguis Draxonis 10g, catechu 12g, Cortex Hibisci 8g, Hippocampus 6g, Radix Saposhnikoviae 4g, Rhizoma Phragmitis 6g, Radix Sophorae Flavescentis 8g, Rhizoma Smilacis Glabrae 12g, Radix Paeoniae Rubra 8g, Herba Siegesbeckiae 6g, Ramulus Mori 4g.
Preparation method: the mode effective component extracting each taste medicine in above-mentioned Recipe of external-use medicine being adopted respectively water extraction or ethanol extraction, by the effective ingredient mixing of extracting, loads in bottle stand-by.
Usage: during use, gets appropriate medicated powder, instant with 97% ethanol, and darken blue rear wiping site of disease.General one month is a course for the treatment of, and 3-6 the course for the treatment of takes effect.
Medicine is avoided: 1) should wash away medicinal liquid, with anti-foaming after local application's number minute.As there is erythema, blister, should suspend medication, can continue to use after to be restored.2) ban on opium-smoking and the opium trade wine.
Embodiment 3
One removes vitiligo cream, is made up of the component of following weight: Fructus Psoraleae 20g, Rhizoma Drynariae 30g, Radix Sorghum vulgare Pers. 8g, Caulis Vernoniae andersonii 30g, Ramulus et Folium Mussaendae Pubescentis 10g, Radix Ampelopsis 12g, Fructus Bruceae 4g, Radix Cynanchi Paniculati 12g, Caulis Trachelospermi 8g, Sanguis Draxonis 20g, catechu 8g, Cortex Hibisci 12g, Hippocampus 4g, Radix Saposhnikoviae 6g, Rhizoma Phragmitis 4-6g, Radix Sophorae Flavescentis 8g, Rhizoma Smilacis Glabrae 12g, Radix Paeoniae Rubra 8g, Herba Siegesbeckiae 6g, Ramulus Mori 4g.
Preparation method: the mode effective component extracting each taste medicine in above-mentioned Recipe of external-use medicine being adopted respectively water extraction or ethanol extraction, by the effective ingredient mixing of extracting, loads in bottle stand-by.
Usage: during use, gets appropriate medicated powder, instant with 97% ethanol, and darken blue rear wiping site of disease.General one month is a course for the treatment of, and 3-6 the course for the treatment of takes effect.
Medicine is avoided: 1) should wash away medicinal liquid, with anti-foaming after local application's number minute.As there is erythema, blister, should suspend medication, can continue to use after to be restored.2) ban on opium-smoking and the opium trade wine.
Model case
Beam so-and-so, 12 years old, female, Anhui Province Fuyang City people.The first visit time is on June 14th, 2012, and diseased region is above the left side corners of the mouth is outer, and left index finger metacarpophalangeal joint, by the embodiment of the present invention 1 Drug therapy 4 months, cures, follow up a case by regular visits to and do not recur for 1 year.
Wu so-and-so, 26 years old, man, people from Jieshou City, Anhui Province.The first visit time is on April 16th, 2013, and diseased region is whole scalp, face, chest, abdominal part, and by the embodiment of the present invention 2 Drug therapy 6 months, therapeutic outcome was fully recovered.
Often so-and-so, male, 6 years old, people from Jieshou City, Anhui Province.April 16 2014 first visit time.Site of pathological change women's head-ornaments, extremity, back, buttocks, by the embodiment of the present invention 3 Drug therapy 5 months, therapeutic outcome was fully recovered.
More than show and describe ultimate principle of the present invention and principal character and advantage of the present invention.The technical staff of the industry should understand; the present invention is not restricted to the described embodiments; what describe in above-described embodiment and description just illustrates principle of the present invention; without departing from the spirit and scope of the present invention; the present invention also has various changes and modifications, and these changes and improvements all fall in the claimed scope of the invention.Application claims protection domain is defined by appending claims and equivalent thereof.
Claims (2)
1. one kind is removed vitiligo cream, it is characterized in that, be made up of the component of following weight: Fructus Psoraleae 20-30g, Rhizoma Drynariae 20-30g, Radix Sorghum vulgare Pers. 8-12g, Caulis Vernoniae andersonii 20-30g, Ramulus et Folium Mussaendae Pubescentis 10-20g, Radix Ampelopsis 8-12g, Fructus Bruceae 4-6g, Radix Cynanchi Paniculati 8-12g, Caulis Trachelospermi 8-12g, Sanguis Draxonis 10-20g, catechu 8-12g, Cortex Hibisci 8-12g, Hippocampus 4-6g, Radix Saposhnikoviae 4-6g, Rhizoma Phragmitis 4-6g, Radix Sophorae Flavescentis 8-12g, Rhizoma Smilacis Glabrae 8-12g, Radix Paeoniae Rubra 8-12g, Herba Siegesbeckiae 4-6g, Ramulus Mori 4-6g.
2. according to claim 1ly remove vitiligo cream, it is characterized in that: be made up of the component of following weight: Fructus Psoraleae 25g, Rhizoma Drynariae 25g, Radix Sorghum vulgare Pers. 10g, Caulis Vernoniae andersonii 25g, Ramulus et Folium Mussaendae Pubescentis 15g, Radix Ampelopsis 10g, Fructus Bruceae 5g, Radix Cynanchi Paniculati 10g, Caulis Trachelospermi 10g, Sanguis Draxonis 15g, catechu 10g, Cortex Hibisci 10g, Hippocampus 5g, Radix Saposhnikoviae 5g, Rhizoma Phragmitis 5g, Radix Sophorae Flavescentis 10g, Rhizoma Smilacis Glabrae 10g, Radix Paeoniae Rubra 10g, Herba Siegesbeckiae 5g, Ramulus Mori 5g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510209162.0A CN104840784A (en) | 2015-04-24 | 2015-04-24 | Vitiligo eliminating ointment |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510209162.0A CN104840784A (en) | 2015-04-24 | 2015-04-24 | Vitiligo eliminating ointment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104840784A true CN104840784A (en) | 2015-08-19 |
Family
ID=53841029
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510209162.0A Pending CN104840784A (en) | 2015-04-24 | 2015-04-24 | Vitiligo eliminating ointment |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104840784A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1174071A (en) * | 1997-07-12 | 1998-02-25 | 迟经惠 | Ointment for purpura nervosa and leukoderma |
| CN1181970A (en) * | 1997-11-14 | 1998-05-20 | 黄国泉 | Externally painted medicine for vitiligo and its preparation |
| CN101664436A (en) * | 2008-09-04 | 2010-03-10 | 谭汉卿 | Chinese medicinal liniment for treating vitiligo |
| CN102462731A (en) * | 2012-01-05 | 2012-05-23 | 刘爱玲 | External ointment for treating vitiligo |
| CN103893705A (en) * | 2014-04-18 | 2014-07-02 | 山东省千佛山医院 | Traditional Chinese medicine for treating leucoderma by oral administration and washout |
-
2015
- 2015-04-24 CN CN201510209162.0A patent/CN104840784A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1174071A (en) * | 1997-07-12 | 1998-02-25 | 迟经惠 | Ointment for purpura nervosa and leukoderma |
| CN1181970A (en) * | 1997-11-14 | 1998-05-20 | 黄国泉 | Externally painted medicine for vitiligo and its preparation |
| CN101664436A (en) * | 2008-09-04 | 2010-03-10 | 谭汉卿 | Chinese medicinal liniment for treating vitiligo |
| CN102462731A (en) * | 2012-01-05 | 2012-05-23 | 刘爱玲 | External ointment for treating vitiligo |
| CN103893705A (en) * | 2014-04-18 | 2014-07-02 | 山东省千佛山医院 | Traditional Chinese medicine for treating leucoderma by oral administration and washout |
Non-Patent Citations (1)
| Title |
|---|
| 翁维良: "《中医活血化瘀治疗疑难病》", 31 August 2011, 金盾出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101804185B (en) | Chinese medicinal compound extract for whitening and removing freckles and preparation method thereof | |
| CN102284051B (en) | Medicine for treating chloasma | |
| CN103393903B (en) | Medicament for treating leucoderma | |
| CN101637512B (en) | Traditional Chinese medicine preparation for treating vitiligo | |
| CN101926857B (en) | Traditional Chinese medicinal liniment for treating vitiligo | |
| CN101391047A (en) | Traditional Chinese medicine preparation for treating trichonosis | |
| CN104173607A (en) | Pharmaceutical composition for treating chloasma and preparation method thereof | |
| CN101057922B (en) | Traditional Chinese medicine preparation for treating vitiligo | |
| CN103223048B (en) | Traditional Chinese medicine composition for treating facial leukoderma | |
| CN103816233A (en) | Externally-used traditional Chinese medicinal composition for treating incomplete vitiligo | |
| CN105796714A (en) | Traditional Chinese medicine acupoint plaster | |
| CN101940624B (en) | Chinese medicinal lotion for treating vitiligo | |
| CN101804179B (en) | Traditional Chinese medicine composition for treating hyperosteogeny of cervical vertebra and lumbar vertebra and preparation method thereof | |
| CN104840784A (en) | Vitiligo eliminating ointment | |
| CN1250260C (en) | Medicine against psoriasis | |
| CN101129718B (en) | Traditional Chinese medicine preparation for treating leuoderma | |
| CN103948684A (en) | Externally-applied liniment for treating leucoderma | |
| CN103463611B (en) | Traditional Chinese medicine composite for treating seborrhoeic alopecia and preparing method thereof | |
| CN103933336A (en) | Traditional Chinese medicine combination for treating leucoderma | |
| CN101940695B (en) | Chinese medicinal ointment for treating vitiligo and preparation method thereof | |
| CN1141124C (en) | Chinese medicine preparation for treating leukoderma and its preparation | |
| CN105362519A (en) | Traditional Chinese medicinal composition for treating chloasma | |
| CN101940657B (en) | Capsules for treating leucoderma and preparation method thereof | |
| CN104013940A (en) | Traditional Chinese medicine for fumigation foot bath to treat insomnia | |
| CN107648511A (en) | Treat Chinese medicine preparation and the preparation of women chloasma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150819 |
|
| RJ01 | Rejection of invention patent application after publication |